BioSyent Inc. (BIOYF)
OTCMKTS · Delayed Price · Currency is USD
8.72
+0.15 (1.70%)
Sep 17, 2025, 2:16 PM EDT
BioSyent Market Cap
BioSyent has a market cap or net worth of $98.23 million as of September 17, 2025. Its market cap has increased by 15.94% in one year.
Market Cap
98.23M
Enterprise Value
84.11M
Revenue
28.97M
Ranking
n/a
PE Ratio
16.22
Stock Price
$8.72
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 9.48M to 98.23M, an increase of 936.05%. That is a compound annual growth rate of 8.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 98.23M | 10.69% |
| Dec 31, 2024 | 88.75M | 8.08% |
| Dec 29, 2023 | 82.11M | 31.23% |
| Dec 30, 2022 | 62.57M | -23.01% |
| Dec 30, 2021 | 81.27M | 2.23% |
| Dec 31, 2020 | 79.49M | 24.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |